NYU Langone and Sage Bionetworks Receive $25 Million Grant for Innovative Human-Based Testing Data Hub

A groundbreaking initiative is underway, supported by a generous $25 million grant from the National Institutes of Health (NIH), aimed at enhancing human-based testing methodologies. A collaborative effort between NYU Langone Health and Sage Bionetworks, the grant is intended to create a centralized data hub and coordination center under the NIH's Complement-Animal Research in Experimentation (Complement-ARIE) program.

Objectives of the Complement-ARIE Program

The primary goal of the Complement-ARIE program is to expedite the advancement of New Approach Methodologies (NAMs). Traditional methods of testing on animal models are increasingly being complemented or even replaced by lab- or computer-based approaches that provide a more accurate representation of human biology. This transition is particularly crucial in fields where health and safety protocols must adhere to stringent standards.

The project will focus on developing several innovative technologies, including complex three-dimensional human-based cell systems, such as organoid platforms and organ-on-a-chip technologies. Additionally, it will explore the use of artificial intelligence and machine learning models, as well as cell-free biochemical assays for toxicology screenings—a significant leap forward in pharmaceutical and medical research.

Grant Details and Data Hub Functionality

The NIH funding will provide NYU Langone and Sage with $5 million annually for five years, ultimately totaling $25 million. This financial backing will facilitate the establishment of the NYU-Sage NAMs Data Hub and Coordination Center (NYU-Sage NDHCC). This advanced data hub will standardize and harmonize datasets ranging from molecular tests to complex 3D cultures and simulated population outcomes.

Key functionalities of the hub include harnessing cloud technology to serve as a backbone for a wide array of data, metadata, code, and computational models. The integration of AI will enhance data curation, establishing a robust framework for harmonizing NAMs data across various research projects. This will not only streamline the analytical processes but will also encourage broader collaboration among all research teams involved in the Complement-ARIE consortium.

Enhancing Collaboration and Interoperability

One of the uniquely defining aspects of the NYU-Sage NDHCC will be its adherence to the FAIR, Unified Schema for Interoperability of Ontologies in NAMs (FUSION) framework. This comprehensive approach to data standards will adapt as the NAMs field evolves, ensuring that diverse experimental and in silico data remains interoperable and reusable. This adaptability fosters creativity and innovation in research methodologies within the life sciences.

Gustavo A. Stolovitzky, PhD, who serves as the director of the Biomedical Data Sciences Hub at NYU and the principal investigator for the project, articulated the transformative potential of this initiative: "Our joint team will advance the understanding of human health and disease by coordinating the full spectrum of data generated across the consortium. This work will ultimately turn disparate datasets into a valuable resource, propelling new discoveries for our team, collaborating partners, and the broader research community."

Principal Investigators Supporting the Initiative

Alongside Dr. Stolovitzky, other principal investigators include Jineta Banerjee, PhD, from Sage Bionetworks; David Fenyo, PhD, from NYU's Institute for Systems Genetics; Stuart D. Katz, MD, from the Department of Medicine at NYU; and Chang Yu, PhD, from the Department of Population Health at NYU. Together, this team brings unparalleled expertise and vision to the ambitious project.

Complement-ARIE will also fund technology development centers at various institutions, all integrated through the NYU-Sage data hub. This collaborative network will generate NAM technologies targeting critical scientific challenges, while the Validation and Qualification Network will set standard validation criteria for NAMs, combining industry and regulatory expertise.

Final Thoughts

This landmark initiative exemplifies how modern technology and innovative approaches can redefine research methodologies in health and medicine. By fostering a paradigm shift—from traditional animal testing to human-centric models—NYU Langone Health and Sage Bionetworks are poised to contribute significantly to improving human health outcomes.

With the backing of the NIH Common Fund, which emphasizes transformative, high-impact programs, this grant represents not only a significant investment in biomedical research but also a leap towards more ethical, effective testing alternatives.